T. Rowe Price Associates
RARX

T. Rowe Price Associates’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-9,640
Closed -$463K 2583
2020
Q1
$463K Buy
+9,640
New +$463K ﹤0.01% 2022